Buscar
Milestone Pharmaceuticals Inc
MISTAñadir a la lista de seguimiento
1.320USD
0.0000.00%
Cierre 07/02, 13:00（ET）Cotizaciones retrasadas 15 min
155.49MCap. mercado
PérdidaP/E TTM
Más Datos de Milestone Pharmaceuticals Inc Compañía
Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia, atrial fibrillation, and other cardiovascular indications.
Información de Milestone Pharmaceuticals Inc
Símbolo de cotizaciónMIST
Nombre de la empresaMilestone Pharmaceuticals Inc
Fecha de salida a bolsaMay 09, 2019
Director ejecutivoOliveto (Joseph)
Número de empleados33
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 09
Dirección420-1111 boul. Dr.-Frederik-Philips
CiudadMONTREAL
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísCanada
Código postalH4M 2X6
Teléfono15143360444
Sitio Webhttps://www.milestonepharma.com
Símbolo de cotizaciónMIST
Fecha de salida a bolsaMay 09, 2019
Director ejecutivoOliveto (Joseph)
Ejecutivos de Milestone Pharmaceuticals Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. David Bharucha
Dr. David Bharucha
Chief Medical Officer
Chief Medical Officer
113.18K
-13.36%
Mr. Amit Hasija
Mr. Amit Hasija
Chief Financial Officer, Executive Vice President - Corporate Development
Chief Financial Officer, Executive Vice President - Corporate Development
99.85K
-19.23%
Dr. Robert James Wills, Ph.D.
Dr. Robert James Wills, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
65.00K
--
Mr. Michael John Tomsicek
Mr. Michael John Tomsicek
Independent Director
Independent Director
15.00K
+0.01%
Mr. Joseph Oliveto
Mr. Joseph Oliveto
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Lisa M. Giles
Ms. Lisa M. Giles
Independent Director
Independent Director
--
--
Mr. Lorenz Muller
Mr. Lorenz Muller
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Seth H. Z. Fischer
Mr. Seth H. Z. Fischer
Independent Director
Independent Director
--
--
Mr. Jeffrey Nelson
Mr. Jeffrey Nelson
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Stuart Duty
Mr. Stuart Duty
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. David Bharucha
Dr. David Bharucha
Chief Medical Officer
Chief Medical Officer
113.18K
-13.36%
Mr. Amit Hasija
Mr. Amit Hasija
Chief Financial Officer, Executive Vice President - Corporate Development
Chief Financial Officer, Executive Vice President - Corporate Development
99.85K
-19.23%
Dr. Robert James Wills, Ph.D.
Dr. Robert James Wills, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
65.00K
--
Mr. Michael John Tomsicek
Mr. Michael John Tomsicek
Independent Director
Independent Director
15.00K
+0.01%
Mr. Joseph Oliveto
Mr. Joseph Oliveto
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Lisa M. Giles
Ms. Lisa M. Giles
Independent Director
Independent Director
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Milestone Pharmaceuticals Inc?
Los cinco principales accionistas de Milestone Pharmaceuticals Inc son: Dr. David Bharucha
¿Cuántas instituciones poseen acciones de Milestone Pharmaceuticals Inc (MIST)?
A fecha de 2026Q1, 133 instituciones poseen acciones de Milestone Pharmaceuticals Inc, con un valor de mercado combinado de aproximadamente 30.89M, lo que representa el 25.86% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -18702702.00.